Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) shot up 16.9% during mid-day trading on Wednesday . The company traded as high as $13.09 and last traded at $12.94. 815,014 shares changed hands during trading, a decline of 20% from the average session volume of 1,025,065 shares. The stock had previously closed at […]
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $9.52 and last traded at $10.74, with a volume of 594318 shares traded. The stock had previously closed at $9.94. Analyst Ratings Changes A number of equities analysts have […]
Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday . The company traded as low as $9.52 and last traded at $10.74, with a volume of 594318 shares traded. The stock had previously closed at $9.94. Analyst Ratings Changes A number of equities analysts have […]
PHILADELPHIA, May 29, 2024 (GLOBE NEWSWIRE) Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for
HC Wainwright restated their buy rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research report released on Friday, Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. Other equities research analysts have also issued reports about the stock. Wells Fargo & Company increased their target price on […]